{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:15:43Z","timestamp":1787008543484,"version":"build-2736575974"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>High-throughput DNA sequencing is increasingly employed to diagnose single gene neurological and neuromuscular disorders. Large volumes of data present new challenges in data interpretation and its useful translation into clinical and genetic counselling for families. Even when a plausible gene is identified with confidence, interpretation of the clinical significance and inheritance pattern of variants can be challenging. We report our approach to evaluating variants in the skeletal muscle chloride channel ClC-1 identified in 223 probands with myotonia congenita as an example of these challenges. Sequencing of CLCN1, the gene that encodes CLC-1, is central to the diagnosis of myotonia congenita. However, interpreting the pathogenicity and inheritance pattern of novel variants is notoriously difficult as both dominant and recessive mutations are reported throughout the channel sequence, ClC-1 structure-function is poorly understood and significant intra- and interfamilial variability in phenotype is reported.<\/jats:p>\n                  <jats:p>Heterologous expression systems to study functional consequences of CIC-1 variants are widely reported to aid the assessment of pathogenicity and inheritance pattern. However, heterogeneity of reported analyses does not allow for the systematic correlation of available functional and genetic data. We report the systematic evaluation of 95 CIC-1 variants in 223 probands, the largest reported patient cohort, in which we apply standardized functional analyses and correlate this with clinical assessment and inheritance pattern. Such correlation is important to determine whether functional data improves the accuracy of variant interpretation and likely mode of inheritance.<\/jats:p>\n                  <jats:p>Our data provide an evidence-based approach that functional characterization of ClC-1 variants improves clinical interpretation of their pathogenicity and inheritance pattern, and serve as reference for 34 previously unreported and 28 previously uncharacterized CLCN1 variants. In addition, we identify novel pathogenic mechanisms and find that variants that alter voltage dependence of activation cluster in the first half of the transmembrane domains and variants that yield no currents cluster in the second half of the transmembrane domain. None of the variants in the intracellular domains were associated with dominant functional features or dominant inheritance pattern of myotonia congenita.<\/jats:p>\n                  <jats:p>Our data help provide an initial estimate of the anticipated inheritance pattern based on the location of a novel variant and shows that systematic functional characterization can significantly refine the assessment of risk of an associated inheritance pattern and consequently the clinical and genetic counselling.<\/jats:p>","DOI":"10.1093\/brain\/awab344","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T15:14:06Z","timestamp":1631546046000},"page":"607-620","source":"Crossref","is-referenced-by-count":20,"title":["Translating genetic and functional data into clinical practice: a series of 223 families with myotonia"],"prefix":"10.1093","volume":"145","author":[{"given":"Karen","family":"Suetterlin","sequence":"first","affiliation":[{"name":"MRC International Centre for Genomic Medicine in Neuromuscular Diseases, Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology, London, UK"},{"name":"AGE Research Group, NIHR Newcastle Biomedical Research Centre, Newcastle-upon-Tyne Hospitals NHS Foundation Trust and Newcastle University, Newcastle-upon-Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Matthews","sequence":"additional","affiliation":[{"name":"MRC International Centre for Genomic Medicine in Neuromuscular Diseases, Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology, London, UK"},{"name":"Atkinson Morley Neuromuscular Centre, Department of Neurology, St Georges University Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Sud","sequence":"additional","affiliation":[{"name":"Neurogenetics Unit, UCL Queen Square Institute of Neurology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"McCall","sequence":"additional","affiliation":[{"name":"Neurogenetics Unit, UCL Queen Square Institute of Neurology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Fialho","sequence":"additional","affiliation":[{"name":"MRC International Centre for Genomic Medicine in Neuromuscular Diseases, Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology, London, UK"},{"name":"Department of Clinical Neurophysiology, King\u2019s College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Burge","sequence":"additional","affiliation":[{"name":"MRC International Centre for Genomic Medicine in Neuromuscular Diseases, Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology, London, UK"},{"name":"Department of Clinical Neurophysiology, King\u2019s College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipa","family":"Jayaseelan","sequence":"additional","affiliation":[{"name":"MRC International Centre for Genomic Medicine in Neuromuscular Diseases, Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Haworth","sequence":"additional","affiliation":[{"name":"Neurogenetics Unit, UCL Queen Square Institute of Neurology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary G","family":"Sweeney","sequence":"additional","affiliation":[{"name":"Neurogenetics Unit, UCL Queen Square Institute of Neurology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri M","family":"Kullmann","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Schorge","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK"},{"name":"Department of Pharmacology, UCL School of Pharmacy, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G","family":"Hanna","sequence":"additional","affiliation":[{"name":"MRC International Centre for Genomic Medicine in Neuromuscular Diseases, Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roope","family":"M\u00e4nnikk\u00f6","sequence":"additional","affiliation":[{"name":"MRC International Centre for Genomic Medicine in Neuromuscular Diseases, Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"issue":"16","key":"2022041812231454500_awab344-B1","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1212\/WNL.0b013e31828cf8d0","article-title":"Prevalence study of genetically defined skeletal muscle channelopathies in England","volume":"80","author":"Horga","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"2022041812231454500_awab344-B2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1113\/jphysiol.1971.sp009667","article-title":"Chloride conductance in normal and myotonic muscle fibres and the action of monocarboxylic aromatic acids","volume":"219","author":"Bryant","year":"1971","journal-title":"J Physiol"},{"issue":"5071","key":"2022041812231454500_awab344-B3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1379744","article-title":"The skeletal muscle chloride channel in dominant and recessive human myotonia","volume":"257","author":"Koch","year":"1992","journal-title":"Science (New York, NY)"},{"issue":"4","key":"2022041812231454500_awab344-B4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/ng0493-305","article-title":"Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita)","volume":"3","author":"George","year":"1993","journal-title":"Nat Genet"},{"issue":"4","key":"2022041812231454500_awab344-B5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.nmd.2015.01.006","article-title":"SCN4A mutation as modifying factor of myotonic dystrophy type 2 phenotype","volume":"25","author":"Bugiardini","year":"2015","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"2022041812231454500_awab344-B6","doi-asserted-by":"crossref","first-page":"11058","DOI":"10.1038\/s41598-018-29302-z","article-title":"SCN4A as modifier gene in patients with myotonic dystrophy type 2","volume":"8","author":"Binda","year":"2018","journal-title":"Sci Rep"},{"issue":"10","key":"2022041812231454500_awab344-B7","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1007\/s00415-012-6462-1","article-title":"Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2","volume":"259","author":"Cardani","year":"2012","journal-title":"J Neurol"},{"issue":"11","key":"2022041812231454500_awab344-B8","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.nmd.2014.06.439","article-title":"Heterozygous CLCN1 mutations can modulate phenotype in sodium channel myotonia","volume":"24","author":"Furby","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"2022041812231454500_awab344-B9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jns.2016.08.030","article-title":"A case of non-dystrophic myotonia with concomitant mutations in the SCN4A and CLCN1 genes","volume":"369","author":"Kato","year":"2016","journal-title":"J Neurol Sci"},{"issue":"4","key":"2022041812231454500_awab344-B10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10048-017-0525-5","article-title":"Coexistence of CLCN1 and SCN4A mutations in one family suffering from myotonia","volume":"18","author":"Maggi","year":"2017","journal-title":"Neurogenetics"},{"issue":"1","key":"2022041812231454500_awab344-B11","doi-asserted-by":"crossref","first-page":"17560","DOI":"10.1038\/s41598-019-54041-0","article-title":"Myotonia in a patient with a mutation in an S4 arginine residue associated with hypokalaemic periodic paralysis and a concomitant synonymous CLCN1 mutation","volume":"9","author":"Thor","year":"2019","journal-title":"Sci Rep"},{"issue":"9","key":"2022041812231454500_awab344-B12","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1073\/pnas.81.9.2772","article-title":"Dimeric structure of single chloride channels from Torpedo electroplax","volume":"81","author":"Miller","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6869","key":"2022041812231454500_awab344-B13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/415287a","article-title":"X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity","volume":"415","author":"Dutzler","year":"2002","journal-title":"Nature"},{"issue":"4947","key":"2022041812231454500_awab344-B14","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.2156338","article-title":"Steady-state coupling of ion-channel conformations to a transmembrane ion gradient","volume":"247","author":"Richard","year":"1990","journal-title":"Science (New York, NY)"},{"issue":"6514","key":"2022041812231454500_awab344-B15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/373527a0","article-title":"Gating of the voltage-dependent chloride channel CIC-0 by the permeant anion","volume":"373","author":"Pusch","year":"1995","journal-title":"Nature"},{"issue":"Pt 2","key":"2022041812231454500_awab344-B16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1113\/jphysiol.1996.sp021778","article-title":"Concentration and pH dependence of skeletal muscle chloride channel ClC-1","volume":"497","author":"Rychkov","year":"1996","journal-title":"J Physiol"},{"issue":"6","key":"2022041812231454500_awab344-B17","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/0896-6273(95)90023-3","article-title":"Mutations in dominant human myotonia congenita drastically alter the voltage dependence of the CIC-1 chloride channel","volume":"15","author":"Pusch","year":"1995","journal-title":"Neuron"},{"issue":"Pt 12","key":"2022041812231454500_awab344-B18","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1093\/brain\/awm248","article-title":"Chloride channel myotonia: Exon 8 hot-spot for dominant-negative interactions","volume":"130","author":"Fialho","year":"2007","journal-title":"Brain"},{"issue":"11","key":"2022041812231454500_awab344-B19","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/hmg\/7.11.1753","article-title":"ClC-1 chloride channel mutations in myotonia congenita: Variable penetrance of mutations shifting the voltage dependence","volume":"7","author":"Kubisch","year":"1998","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2022041812231454500_awab344-B20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.nmd.2011.10.013","article-title":"Screening for mutations in Spanish families with myotonia. Functional analysis of novel mutations in CLCN1 gene","volume":"22","author":"Mazon","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"2022041812231454500_awab344-B21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/humu.22916","article-title":"Identification and functional characterization of CLCN1 mutations found in nondystrophic myotonia patients","volume":"37","author":"Vindas-Smith","year":"2016","journal-title":"Hum Mutat"},{"issue":"5","key":"2022041812231454500_awab344-B22","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/hmg\/6.5.805","article-title":"Identification of functionally important regions of the muscular chloride channel CIC-1 by analysis of recessive and dominant myotonic mutations","volume":"6","author":"Wollnik","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"18","key":"2022041812231454500_awab344-B23","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1113\/JP270358","article-title":"ClC-1 mutations in myotonia congenita patients: Insights into molecular gating mechanisms and genotype-phenotype correlation","volume":"593","author":"Imbrici","year":"2015","journal-title":"J Physiol"},{"issue":"9","key":"2022041812231454500_awab344-B24","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/humu.23581","article-title":"The analysis of myotonia congenita mutations discloses functional clusters of amino acids within the CBS2 domain and the C-terminal peptide of the ClC-1 channel","volume":"39","author":"Altamura","year":"2018","journal-title":"Hum Mutat"},{"issue":"3-4","key":"2022041812231454500_awab344-B25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000356353","article-title":"KCNJ10 mutations display differential sensitivity to heteromerisation with KCNJ16","volume":"123","author":"Parrock","year":"2013","journal-title":"Nephron Physiol"},{"issue":"5","key":"2022041812231454500_awab344-B26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.nmd.2018.03.006","article-title":"Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands","volume":"28","author":"Stunnenberg","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"2022041812231454500_awab344-B27","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1212\/WNL.54.4.937","article-title":"Functional consequences of chloride channel gene (CLCN1) mutations causing myotonia congenita","volume":"54","author":"Zhang","year":"2000","journal-title":"Neurology"},{"issue":"6","key":"2022041812231454500_awab344-B28","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/hmg\/3.6.941","article-title":"Genomic organization of the human muscle chloride channel CIC-1 and analysis of novel mutations leading to Becker-type myotonia","volume":"3","author":"Lorenz","year":"1994","journal-title":"Hum Mol Genet"},{"issue":"5","key":"2022041812231454500_awab344-B29","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s11033-014-3142-5","article-title":"In vitro analysis of splice site mutations in the CLCN1 gene using the minigene assay","volume":"41","author":"Ulzi","year":"2014","journal-title":"Mol Biol Rep"},{"issue":"45","key":"2022041812231454500_awab344-B30","doi-asserted-by":"crossref","first-page":"32780","DOI":"10.1074\/jbc.M703259200","article-title":"Inhibition of skeletal muscle ClC-1 chloride channels by low intracellular pH and ATP","volume":"282","author":"Bennetts","year":"2007","journal-title":"J Biol Chem"},{"issue":"6","key":"2022041812231454500_awab344-B31","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1159\/000315088","article-title":"Functional study of CLC-1 mutants expressed in Xenopus oocytes reveals that a C-terminal region Thr891-Ser892-Thr893 is responsible for the effects of protein kinase C activator","volume":"25","author":"Hsiao","year":"2010","journal-title":"Cell Physiol Biochem"},{"key":"2022041812231454500_awab344-B32","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36629","article-title":"Structure of the CLC-1 chloride channel from Homo sapiens","volume":"7","author":"Park","year":"2018","journal-title":"eLife"},{"issue":"2","key":"2022041812231454500_awab344-B33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0896-6273(95)90050-0","article-title":"An aspartic acid residue important for voltage-dependent gating of human muscle chloride channels","volume":"15","author":"Fahlke","year":"1995","journal-title":"Neuron"},{"issue":"4","key":"2022041812231454500_awab344-B34","doi-asserted-by":"crossref","first-page":"e3000218","DOI":"10.1371\/journal.pbio.3000218","article-title":"Structure of the human ClC-1 chloride channel","volume":"17","author":"Wang","year":"2019","journal-title":"PLoS Biology"},{"issue":"3","key":"2022041812231454500_awab344-B35","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3233\/JND-200582","article-title":"Targeted therapies for skeletal muscle ion channelopathies: Systematic review and steps towards precision medicine","volume":"8","author":"Desaphy","year":"2021","journal-title":"J Neuromuscul Dis"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awab344\/42629045\/awab344.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/145\/2\/607\/43390382\/awab344.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/145\/2\/607\/43390382\/awab344.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T08:27:34Z","timestamp":1650270454000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/145\/2\/607\/6371181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,9,16]]},"published-print":{"date-parts":[[2022,4,18]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awab344","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2021,9,16]]}}}